#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11196	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2194	504.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	602	C,T	584,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11196	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2194	504.3	0	HET	.	.	.	C1450T	.	1450	1450	C	1685	1685	C	630	C,T	484,125	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20664	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	581.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1659	1659	A	669	A,C,G	647,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20664	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	581.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2293	2293	C	634	C	617	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20664	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	581.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2367	2367	A	639	A	619	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20664	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	581.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2919	2919	C	613	C,T	594,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20664	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	581.3	0	HET	.	.	.	T695C	.	695	695	T	1017	1017	T	659	T,C	489,148	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20664	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	581.3	0	HET	.	.	.	A1148AT,ATT	.	1148	1148	A	1470	1470	A	695	AT,ATT	514,146	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	37740	blaTEM	861	861	99.88	blaTEM.l15.c17.ctg.1	1607	2329.7	0	.	p	.	0	M180T	NONSYN	538	540	ATG	845	847	ACG	3360;3367;3351	A,C;C,T,G,A;G,C	3241,2;3294,1,1,1;3268,2	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1380	folP	855	855	100.0	folP.l15.c4.ctg.1	1581	86.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1088	1090	AGC	148;147;147	A;G;C	142;142;142	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3842	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3330	114.7	1	SNP	p	S91F	1	.	.	271	273	TTC	523	525	TTC	120;119;120	T;T;C	119;118;115	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3842	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3330	114.7	1	SNP	p	D95G	1	.	.	283	285	GGC	535	537	GGC	122;122;121	G;G;C	118;118;117	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3842	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3330	114.7	1	SNP	p	G95N	0	.	.	283	285	GGC	535	537	GGC	122;122;121	G;G;C	118;118;117	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1136	mtrR	633	633	98.74	mtrR.l15.c4.ctg.1	1384	81.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	453	455	ACC	112;113;114	A,G;C;C	108,2;113;114	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1136	mtrR	633	633	98.74	mtrR.l15.c4.ctg.1	1384	81.6	0	.	p	.	0	S179fs	FSHIFT	535	535	T	872	872	C	126	C	120	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	752	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	961	77.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	0	.	p	.	0	E91G	NONSYN	271	273	GAG	644	646	GGG	130;131;129	G;G,A;G	127;125,3;126	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1676	1678	GCA	145;145;149	G,C;C,T;A,G	137,1;127,5;129,6	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2159	2161	ATT	140;142;142	A,G,T;T;T	129,2,1;135;135	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	1	SNP	p	D86N	0	.	.	256	258	GAC	629	631	GAC	133;131;131	G;A;C	130;128;128	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	1	SNP	p	S87I	0	.	.	259	261	AGT	632	634	AGT	132;132;132	A;G;T	129;129;129	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	1	SNP	p	S87W	0	.	.	259	261	AGT	632	634	AGT	132;132;132	A;G;T	129;129;129	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	1	SNP	p	S87R	0	.	.	259	261	AGT	632	634	AGT	132;132;132	A;G;T	129;129;129	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3360	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3040	109.9	1	SNP	p	S88P	0	.	.	262	264	TCC	635	637	TCC	133;133;132	T;C;C	131;130;129	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3190	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2669	118.9	0	.	p	.	0	V89A	NONSYN	265	267	GTC	576	578	GCC	154;153;150	G;C;C,G	146;148;141,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3190	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2669	118.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1539	1541	GGC	165;163;163	G;G;C	159;160;157	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1287	1289	GCA	175;176;176	G;C;A,C	168;164;170,1	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1290	1292	ATC	174;173;173	A;T;C,G	168;169;166,1	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1302	1304	GTG	175;174;175	G,C;T;G	170,1;168;170	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1302	1304	GTG	175;174;175	G,C;T;G	170,1;168;170	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1806	1808	ACC	137;136;137	A;C;C	130;132;134	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1860	1862	GCG	109;111;110	G;C,G;G	102;94,3;107	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1860	1862	GCG	109;111;110	G;C,G;G	102;94,3;107	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1983	1985	GGC	105;104;101	G;G;C,T	101;100;93,2	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1992	1994	GGC	90;87;87	G,A;G;C	78,2;82;81	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2379	118.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2010	2012	CCG	61;61;59	C,A;C;G	58,1;60;55	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4342	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3147	136.7	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1549	1551	ACG	153;153;152	A,G;C;G	143,3;146;148	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4342	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3147	136.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1687	1689	CTG	144;144;145	C;T;G	134;133;131	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1682	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1738	95.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	325	327	GGC	97;97;100	G,A;G;C	91,2;95;94	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1682	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1738	95.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	507	507	C	108	C,A,G	98,1,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1682	porA	1146	134	98.51	porA.l15.c4.ctg.2	133	0.0	0	.	p	.	0	V76G	NONSYN	226	228	GTG	67	69	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1682	porA	1146	134	98.51	porA.l15.c4.ctg.2	133	0.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	87	87	C	ND	ND	ND	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2132	porB1a	984	984	99.9	porB1a.l15.c17.ctg.1	1355	155.0	0	.	p	.	0	G41R	NONSYN	121	123	GGA	351	353	AGA	158;158;160	A;G;A	154;151;152	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	512	296	porB1b	1035	133	96.24	porB1b.l6.c4.ctg.2	879	16.9	0	.	p	.	0	F56L	NONSYN	166	168	TTC	9	11	TTG	1;1;1	T;T;G,C	1;1;0,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	512	296	porB1b	1035	133	96.24	porB1b.l6.c4.ctg.2	879	16.9	0	.	p	.	0	V75I	NONSYN	223	225	GTT	66	68	ATT	2;3;3	A,G;T;T	0,2;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	512	296	porB1b	1035	143	97.2	porB1b.l6.c4.ctg.4	143	1.4	0	.	p	.	0	A26T	NONSYN	76	78	GCC	43	45	ACC	1;2;2	A,G;C;C	0,1;2;2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	512	296	porB1b	1035	143	97.2	porB1b.l6.c4.ctg.4	143	1.4	0	.	p	.	0	E41K	NONSYN	121	123	GAA	88	90	AAA	2;2;2	A;A;A	2;2;2	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8028	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4711	168.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1912	1914	CAT	170;169;170	C;A;T	165;165;166	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	948	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1176	79.9	1	SNP	p	V57M	1	.	.	169	171	ATG	618	620	ATG	176;175;176	A;T;G	172;172;173	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	8274	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2540	323.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
